Novavax | NVAX - Trade Debtors


Novavax reported $106.45M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Adma Biologics USD 135.86M 22.57M Mar/2026
Agenus USD 22.34M 107K Mar/2026
AstraZeneca USD 18.86B 972M Jun/2026
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Cassava Sciences USD 117K 3K Mar/2026
Geron USD 39.23M 1.57M Dec/2025
GlaxoSmithKline GBP 8.07B 137M Jun/2026
MannKind USD 28.14M 10.23M Mar/2026
Merck USD 12.21B 435M Mar/2026
Moderna USD 17M 54M Jun/2026
Novartis USD 9.6B 2.69B Mar/2026
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 16.19B 19M Jun/2026
Sanofi EUR 492M 10M Jun/2026
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
TG Therapeutics USD 392.05M 86.42M Mar/2026